Skip to main content

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multiple Sclerosis to Evaluate the Efficacy and Safety of BIIB033 as an Add-On Therapy to Anti-Inflammatory Disease-Modifying Therapies

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, MS & Neuroimmunology

Awarded By

Biogen, Inc.

Start Date

January 10, 2018

End Date

August 16, 2021
 

Administered By

Neurology, MS & Neuroimmunology

Awarded By

Biogen, Inc.

Start Date

January 10, 2018

End Date

August 16, 2021